Association of gut microbiota and metabolites with tumor response to immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma.

被引：5
|
作者：
Lee, Pei-Chang
Wu, Chi-Jung
Hung, Ya-Wen
Lee, Chieh-Ju
Chao, Yee
Hou, Ming-Chih
Kuo, Yu-Lun
Chou, Shih-Hsuan
Huang, Yi-Hsiang
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Taipei, Taiwan
[4] Biotools Co Ltd, New Taipei, Taiwan
[5] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Inst Clin Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16165
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
    Muhammed, Ambreen
    D'Alessio, Antonio
    Enica, Andrei
    Talbot, Thomas
    Fulgenzi, Claudia Angela Maria
    Nteliopoulos, Georgios
    Goldin, Robert D.
    Cortellini, Alessio
    Pinato, David J.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (03) : 253 - 264
  • [22] Immune checkpoint inhibitors for hepatocellular carcinoma
    El Dika, Imane
    Khalil, Danny N.
    Abou-Alfa, Ghassan K.
    CANCER, 2019, 125 (19) : 3312 - 3319
  • [23] Safety of drug-eluting beads transarterial chemoembolization under the combination therapy with immune checkpoint inhibitors in unresectable hepatocellular carcinoma.
    Chiu, Sung-Hua
    Chang, Wei-Chou
    Hsieh, Chung-Bao
    Feng, An-Chieh
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 556 - 556
  • [24] Immune checkpoint inhibitors for hepatocellular carcinoma
    Jensen, Christopher E.
    Loaiza-Bonilla, Arturo
    Bonilla-Reyes, Paula A.
    HEPATIC ONCOLOGY, 2016, 3 (03) : 201 - 211
  • [25] Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors
    Wang, Jian
    Yang, Hong-Ru
    Wang, Dai-Jie
    Wang, Xing-Xia
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [26] Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors
    Y. Linda Wu
    Sarah Cappuyns
    Amanda Loh
    Sean Sun
    Sara Lewis
    Max W. Sung
    Myron Schwartz
    Josep M. Llovet
    Deirdre J. Cohen
    BJC Reports, 2 (1):
  • [27] The features of gut microbiota and metabolites in non-viral unresectable hepatocellular carcinoma undergoing immunotherapy
    Lee, Pei-Chang
    Hung, Ya-Wen
    Wu, Chi-Jung
    Lee, Chieh-Ju
    Chi, Chen-Ta
    Lee, I-Cheng
    Kuo, Yu-Lun
    Chou, Shih-Hsuan
    Luo, Jiing-Chyuan
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF HEPATOLOGY, 2024, 80 : S449 - S449
  • [28] Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
    Abenavoli, Ludovico
    Montori, Michele
    Baroni, Gianluca Svegliati
    Argenziano, Maria Eva
    Giorgi, Francesca
    Scarlata, Giuseppe Guido Maria
    Ponziani, Francesca
    Scarpellini, Emidio
    MEDICINA-LITHUANIA, 2023, 59 (08):
  • [29] An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
    Shen, Ying-Chun
    Lee, Pei -Chang
    Kuo, Yu-Lun
    Wu, Wei -Kai
    Chen, Chieh-Chang
    Lei, Chengh-Hau
    Yeh, Ching-Ping
    Hsu, Chiun
    Hsu, Chih-Hung
    Lin, Zhong-Zhe
    Shao, Yu-Yun
    Lu, Li-Chun
    Liu, Tsung-Hao
    Chen, Chien-Hung
    Wu, Ming-Shiang
    Huang, Yi-Hsiang
    Cheng, Ann-Lii
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 809 - 822
  • [30] Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
    Personeni, Nicola
    Pressiani, Tiziana
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Bozzarelli, Silvia
    Terracciano, Luigi
    Dal Buono, Arianna
    Capogreco, Antonio
    Aghemo, Alessio
    Lleo, Ana
    Lutman, Romano Fabio
    Roncalli, Massimo
    Giordano, Laura
    Santoro, Armando
    Di Tommaso, Luca
    Rimassa, Lorenza
    CANCERS, 2021, 13 (22)
12345